Technology | March 22, 2013
Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine), a...
News | February 20, 2013
Guerbet announced that the Medical Imaging Drugs Advisory Committee to U.S. Food and Drug Administration (FDA) has...
Technology | October 28, 2008
Oxilan (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reported...
Technology | November 14, 2007
Guerbet will feature its Oxilan (ioxilan) injection, a contrast agent that is a nonionic low-viscous and low-osmolar
News | October 17, 2007
October 18, 2007 - Guerbet will feature at TCT 2007 its x-ray contrast agent, Oxilan (ioxilan) injection, a contrast
Technology | September 05, 2007
Guerbet’s flagship X-ray contrast agent, Oxilan (ioxilan) injection, is a contrast agent that is a nonionic, low-visc
Technology | August 29, 2006
OXILAN (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity.